BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kourakis S, Timpani CA, Campelj DG, Hafner P, Gueven N, Fischer D, Rybalka E. Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better? Orphanet J Rare Dis 2021;16:117. [PMID: 33663533 DOI: 10.1186/s13023-021-01758-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mantuano P, Boccanegra B, Conte E, De Bellis M, Cirmi S, Sanarica F, Cappellari O, Arduino I, Cutrignelli A, Lopedota AA, Mele A, Denora N, De Luca A. β-Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation. Biomolecules 2021;11:1742. [PMID: 34827740 DOI: 10.3390/biom11111742] [Reference Citation Analysis]
2 Brogi L, Marchese M, Cellerino A, Licitra R, Naef V, Mero S, Bibbiani C, Fronte B. β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy. Nutrients 2021;13:1619. [PMID: 34065946 DOI: 10.3390/nu13051619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 De la Garza-rodea AS, Moore SA, Zamora-pineda J, Hoffman EP, Mistry K, Kumar A, Strober JB, Zhao P, Suh JH, Saba JD. Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice. IJMS 2022;23:7579. [DOI: 10.3390/ijms23147579] [Reference Citation Analysis]
4 Podkalicka P, Mucha O, Kaziród K, Szade K, Stępniewski J, Ivanishchuk L, Hirao H, Pośpiech E, Józkowicz A, Kupiec-Weglinski JW, Dulak J, Łoboda A. miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy. Sci Rep 2022;12:3945. [PMID: 35273230 DOI: 10.1038/s41598-022-07868-z] [Reference Citation Analysis]
5 Cha JJ, Kim IS, Kim JY, Choi EY, Min PK, Yoon YW, Lee BK, Hong BK, Kwon HM, Cho HE, Choi WA, Kang SW, Rim SJ. The association between cardiac involvement and long-term clinical outcomes in patients with Duchenne muscular dystrophy. ESC Heart Fail 2022. [PMID: 35579098 DOI: 10.1002/ehf2.13970] [Reference Citation Analysis]
6 Andre AB, Zhang L, Nix JD, Elmadbouly N, Lucas AR, Wilson-rawls J, Rawls A. Myxomavirus Serp-1 Protein Ameliorates Inflammation in a Mouse Model of Duchenne Muscular Dystrophy. Biomedicines 2022;10:1154. [DOI: 10.3390/biomedicines10051154] [Reference Citation Analysis]
7 Angelini G, Mura G, Messina G. Therapeutic approaches to preserve the musculature in Duchenne Muscular Dystrophy: The importance of the secondary therapies. Exp Cell Res 2022;410:112968. [PMID: 34883113 DOI: 10.1016/j.yexcr.2021.112968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]